In summary, our study showed wide variations in the intensity of a-SMA staining across the samples and together with CD34 staining, and revealed high breast cancer heterogeneity regarding vessel size, perivascular a-SMA status, and vessel density. Here, CD34 is linked to breast carcinoma.